Abstract
Improved serum-free media were developed for the anchorage-dependent growth of A549 human lung carcinoma and B16 mouse melanoma cell lines in vitro. Type 1 transforming growth factor beta (TGF-beta 1) inhibited the growth of A549 or B16 cells under serum-free conditions or in the presence of 10% serum by 15-33%. In contrast, in the presence of micrograms/ml concentrations of polyunsaturated fatty acids (PUFAs), picomolar concentrations of TGF-beta 1 irreversibly inhibited the serum-free growth of A549 or B16 cells by 90-100%. The PUFAs alone had little effect on cell growth. Cell growth inhibition by TGF-beta 1 was not potentiated by saturated fatty acids, monounsaturated fatty acids, or prostaglandins. Inhibition of A549 or B16 cell growth by TGF-beta 1 in the presence of PUFAs was almost completely reversed by the antioxidant vitamin E, suggesting a role for lipid peroxidation in this process. Inhibition of A549 or B16 cell growth by TGF-beta 1 in the presence of 5% fetal calf serum was also potentiated by PUFAs and partially reversed by antioxidants. The presence of retinoic acid was required for maximal PUFA-dependent growth inhibition of A549 or B16 cells by TGF-beta 1 under some, but not all, conditions. These results suggest that inhibition of carcinoma and melanoma cell growth by TGF-beta 1 is mediated, in large part, by PUFAs.
Full text
PDFImages in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boyd F. T., Massagué J. Transforming growth factor-beta inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor. J Biol Chem. 1989 Feb 5;264(4):2272–2278. [PubMed] [Google Scholar]
- Brower M., Carney D. N., Oie H. K., Gazdar A. F., Minna J. D. Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Cancer Res. 1986 Feb;46(2):798–806. [PubMed] [Google Scholar]
- Bégin M. E., Ells G., Das U. N., Horrobin D. F. Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst. 1986 Nov;77(5):1053–1062. [PubMed] [Google Scholar]
- Bégin M. E., Ells G., Horrobin D. F. Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. J Natl Cancer Inst. 1988 Apr 6;80(3):188–194. doi: 10.1093/jnci/80.3.188. [DOI] [PubMed] [Google Scholar]
- Coffey R. J., Jr, Bascom C. C., Sipes N. J., Graves-Deal R., Weissman B. E., Moses H. L. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta. Mol Cell Biol. 1988 Aug;8(8):3088–3093. doi: 10.1128/mcb.8.8.3088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fernandez-Pol J. A., Klos D. J., Grant G. A. Purification and biological properties of type beta transforming growth factor from mouse transformed cells. Cancer Res. 1986 Oct;46(10):5153–5161. [PubMed] [Google Scholar]
- Holley R. W., Baldwin J. H., Greenfield S. Isolation of the BSC-1 monkey kidney cell growth inhibitor. Methods Enzymol. 1987;146:163–167. doi: 10.1016/s0076-6879(87)46018-7. [DOI] [PubMed] [Google Scholar]
- Keski-Oja J., Lyons R. M., Moses H. L. Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-beta 1. Cancer Res. 1987 Dec 15;47(24 Pt 1):6451–6458. [PubMed] [Google Scholar]
- Massagué J. Transforming growth factor-beta modulates the high-affinity receptors for epidermal growth factor and transforming growth factor-alpha. J Cell Biol. 1985 May;100(5):1508–1514. doi: 10.1083/jcb.100.5.1508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mulder K. M., Levine A. E., Hernandez X., McKnight M. K., Brattain D. E., Brattain M. G. Modulation of c-myc by transforming growth factor-beta in human colon carcinoma cells. Biochem Biophys Res Commun. 1988 Jan 29;150(2):711–716. doi: 10.1016/0006-291x(88)90449-4. [DOI] [PubMed] [Google Scholar]
- Nugent M. A., Lane E. A., Keski-Oja J., Moses H. L., Newman M. J. Growth stimulation, altered regulation of epidermal growth factor receptors, and autocrine transformation of spontaneously transformed normal rat kidney cells by transforming growth factor beta. Cancer Res. 1989 Jul 15;49(14):3884–3890. [PubMed] [Google Scholar]
- Nugent M. A., Newman M. J. Inhibition of normal rat kidney cell growth by transforming growth factor-beta is mediated by collagen. J Biol Chem. 1989 Oct 25;264(30):18060–18067. [PubMed] [Google Scholar]
- Roberts A. B., Anzano M. A., Wakefield L. M., Roche N. S., Stern D. F., Sporn M. B. Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci U S A. 1985 Jan;82(1):119–123. doi: 10.1073/pnas.82.1.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roberts A. B., Sporn M. B. Transforming growth factor beta. Adv Cancer Res. 1988;51:107–145. [PubMed] [Google Scholar]
- Sevanian A., Hochstein P. Mechanisms and consequences of lipid peroxidation in biological systems. Annu Rev Nutr. 1985;5:365–390. doi: 10.1146/annurev.nu.05.070185.002053. [DOI] [PubMed] [Google Scholar]
- Sporn M. B., Roberts A. B., Wakefield L. M., de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol. 1987 Sep;105(3):1039–1045. doi: 10.1083/jcb.105.3.1039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Twardzik D. R., Ranchalis J. E., McPherson J. M., Ogawa Y., Gentry L., Purchio A., Plata E., Todaro G. J. Inhibition and promotion of differentiated-like phenotype of a human lung carcinoma in athymic mice by natural and recombinant forms of transforming growth factor-beta. J Natl Cancer Inst. 1989 Aug 2;81(15):1182–1185. doi: 10.1093/jnci/81.15.1182. [DOI] [PubMed] [Google Scholar]